Literature DB >> 3019386

Nucleotide sequence binding preferences of nogalamycin investigated by DNase I footprinting.

K R Fox, M J Waring.   

Abstract

Four DNA restriction fragments, designated tyrT, pTyr2, pUC13, and Xbs1, have been used as substrates for footprinting studies with DNase I in the presence of the anthracycline antibiotic nogalamycin. With each fragment a distinct pattern of antibiotic-protected binding sites is observed, but no concensus sequence emerges from the data. All sites are located in regions of alternating purine-pyrimidine sequence, most commonly associated with the dinucleotide steps TpG (CpA) and GpT (ApC), suggesting that the preferred binding sites may contain all four nucleotides and/or that peculiarities of the dynamics of DNA conformation at alternating sequences may be critical for nogalamycin binding. Some concentration dependence of footprinting patterns is evident, in contrast to previous studies with a variety of sequence-specific ligands. Enhanced susceptibility to attack by DNase I is commonly observed at sequences flanking strong antibiotic-binding sites. Nogalamycin selectively inhibits cleavage of DNA at certain guanine-containing sequences by the G-specific photosensitized reaction with methylene blue. Comparison of these effects with its action on the G-specific reaction with dimethyl sulfate suggests that the amino sugar moiety of nogalamycin may be preferentially located in the minor helical groove at some binding sites but in the major groove at others.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019386     DOI: 10.1021/bi00363a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Sequence-selective binding of an ellipticine derivative to DNA.

Authors:  C Bailly; C OhUigin; C Rivalle; E Bisagni; J P Hénichart; M J Waring
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

Review 2.  DNA structure and perturbation by drug binding.

Authors:  S Neidle; L H Pearl; J V Skelly
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

3.  Sequence-specific binding of luzopeptin to DNA.

Authors:  K R Fox; H Davies; G R Adams; J Portugal; M J Waring
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

4.  Sequence-selective binding of phleomycin to DNA.

Authors:  K R Fox; G W Grigg; M J Waring
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

5.  DNA sequence preferences for an intercalating porphyrin compound revealed by footprinting.

Authors:  K Ford; K R Fox; S Neidle; M J Waring
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

6.  Footprinting at low temperatures: evidence that ethidium and other simple intercalators can discriminate between different nucleotide sequences.

Authors:  K R Fox; M J Waring
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

7.  NMR studies on the binding of antitumor drug nogalamycin to DNA hexamer d(CGTACG).

Authors:  H Robinson; Y C Liaw; G A van der Marel; J H van Boom; A H Wang
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

8.  Conformation and dynamics of the deoxyribose rings of a (nogalamycin)2-d (5'-GCATGC)2 complex studied in solution by 1H-n.m.r. spectroscopy.

Authors:  M S Searle; L P Wakelin
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

9.  Visualising the kinetics of dissociation of actinomycin from individual sites in mixed sequence DNA by DNase I footprinting.

Authors:  M C Fletcher; K R Fox
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

10.  Diethylpyrocarbonate and permanganate provide evidence for an unusual DNA conformation induced by binding of the antitumour antibiotics bleomycin and phleomycin.

Authors:  K R Fox; G W Grigg
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.